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ABSTRACT: The synthesis of a new dinuclear complexes containing linked RuII(dppz) and ReI(dppz) moieties is reported. The photophysi-
cal and biological properties of the new complex, which incorporates a N,N’-bis(4-pyridylmethyl)-1,6-hexanediamine tether ligand, are com-
pared to a previously reported RuII/ReI complex linked by a simple dipyridyl alkane ligand. Although both complexes bind to DNA with simi-
lar affinities, steady state and time resolved photophysical studies reveal that the nature of the linker affects the excited state dynamics of the 
complexes and their DNA photocleavage properties. Quantum based DFT calculations on these systems offers insights into these effects. 
Whilst both complexes are live cells permeant, their intracellular localization are significantly affected by the nature of the linker. Notably, one 
of the complexes displayed concentration dependent localization and possesses photophysical properties that are compatible with SIM and 
STED nanoscopy. This allowed the dynamics of its intracellular localization to be tracked at super resolutions.  
Introduction 
Luminescent d6-metal complexes that interact with biomole-
cules, such as DNA, offer excellent potential as imaging probes 
and as tools to investigate processes such as electron transfer 
within a biological context.1-8 The “DNA light switch” 
[Ru(LL)2(dppz)]2+ (dppz = dipyrido[3,2-a:2’,3’-c]phenazine, LL 
= bidentate ligands such as 2,2’-bipyridine and 1,10-phenanthro-
line) is a well-known example of a complex studied towards these 
goals. It has attracted particular attention as it displays a huge lu-
minescence enhancement (>104) upon intercalation into DNA.9  
Although the chloride salt of the parent complex is not taken 
up by live cells, derivatives that function as cell probes for DNA 
have been reported10,11 Given that these complexes target DNA 
their potential as therapeutics and phototherapeutics has also 
been explored. 12-14 While the excited state of [Ru(LL)2(dppz)]2+ 
itself is not sufficiently oxidizing to cleave DNA directly and the 
intercalated species is a poor singlet oxygen sensitizer,15 com-
plexes with related ancillary ligands16,17 or suitably substituted 
dppz ligands show promising photo-therapeutic properties.18 In 
this context, derivatives of this architecture incorporating the 
RuII(dppn) moiety (dppn = benzo[i]dipyrido[3,2-a:2’,3’-c]phen-
azine), have proven to be excellent  1O2 sensitizers19 and very 
promising leads for photodynamic therapy, PDT.20-22  
Related studies have revealed that ReI complexes - such as 
[Re(CO)3(L)(dppz)]+ (L = monodentate pyridyl ligand) - are 
capable of directly photo-damaging DNA.23-26 However, there are 
drawbacks to these systems compared to their RuII analogues: as 
they are monocations, they possess greatly reduced binding affin-
ity relative to that of the dicationic RuII complex,25 furthermore 
their intraligand 3IL-based emission in water shows a much lower 
enhancement (>13) upon DNA binding compared to the parent 
light-switch complex.24 
The properties of oligonuclear metal complexes for such appli-
cations have also been studied as they are expected to bind to 
larger, or more complex, sites with higher affinities. For example, 
after the Kelly group demonstrated that two linked non-interca-
lating [Ru(bpy)3]2+ units displayed appreciable binding to duplex 
DNA,27,28 Collins, Keene, and colleagues have investigated a 
wide range of oligonuclear analogues with differing linker lengths, 
showing that they bind selectively to non-canonical DNA29 and 
RNA structures3,30 and possess promising antimicrobial proper-
ties.31 
 In terms of metallo-intercalators, pioneering studies by Nor-
dén, Lincoln, and co-workers on the synthesis32 and study33-35 of 
dinuclear [RuII(dppz)] systems connected through the dppz lig-
and showed that although these systems initially groove bind to 
DNA they ultimately intercalate into duplex DNA through a 
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threading mechanism.36-38 However, the construction of such en-
antiopure architectures from kinetically inert optical isomers can 
be challenging. 
With the aim of constructing more complex oligonuclear archi-
tectures,39,40 the Thomas group has investigated the use achiral 
mononuclear complexes as building blocks in the “modular” syn-
thesis of non-threading dinuclear metallo-intercalators.41-44 This 
approach has, inter alia, allowed us to identify RuII(dppn)-based 
systems that are promising leads as sensitizers for PDT45 and it 
has also facilitated the construction of an unique heteronuclear 
complex, 13+ containing both RuII(dppz) and ReI(dppz) units.46 
In our studies on homonuclear RuII systems, we discovered that 
the nature of the tether ligand employed affects the DNA binding 
properties of these systems.44 Therefore - to investigate whether 
similar effects occur in RuII/ReI analogues - we synthesized new 
complex 23+ and compared it to the originally reported system.  
 
Figure 1. Structure of previously reported46 complex 13+ and newly 
synthesized complex 23+ investigated in this study. 
Furthermore, as we have recently demonstrated that RuII com-
plexes are eminently compatible with the super-resolution optical 
microscopy techniques of structured illumination microscopy 
(SIM) and Stimulated emission depletion microscopy (STED),47 
we investigated the potential of these complexes to function as 
imaging probes and theranostics. This allowed us to explore the 
time-dependent uptake of the complexes and provides the first 
example of tracking subcellular localization dynamics of a probe 
within live cells at sub-diffraction limits. This work revealed that 
the photophysics, cellular uptake, localization and even the thera-
peutic potency of these complexes are profoundly dependent on 
the nature of the linker used to tether the RuII(dppz) and 
ReI(dppz) units together. 
Results and Discussion 
Synthesis and characterization 
Complex 13+ was synthesized using a reported method.46 Simi-
larly, complex 23+ was obtained as its hexafluorophosphate salt 
from the reaction of two previously reported mononuclear com-
plexes25,44 using the same procedure employed in the synthesis of 
13+ - See SI for details. Analytically pure samples were isolated 
from repeated anion metathesis and precipitation of its chloride 
salt in acetone, and then its hexafluorophosphate salt in water. 
The UV/Vis absorption spectrum of [2](PF6)3 is similar to 
[1](PF6)3 in that it shows high-energy π®π* transitions, a char-
acteristic structured dppz-based band at ~330 nm, and lower en-
ergy 1MLCT transitions. Excitation into the 1MLCT of 23+ at 431 
nm or the dppz-based band results in unstructured luminescence 
characteristic of the Ru(dπ)®dppz(π*) 3MLCT manifold at 642 
nm, demonstrating that, as in 13+, the excited state of the 
ReI(dppz) unit is deactivated by non-radiative energy transfer to 
the lower-lying Ru-based 3MLCT excited state – see SI. The in-
teraction of [2]Cl3 with calf thymus DNA, CT-DNA, in aqueous 
buffer (25 mM NaCl, 5 m , pH 7.4) was then investigated using 
UV–visible absorption and luminescence titrations.  
Optical studies in the interaction with DNA  
On addition of CT-DNA the absorption spectrum of 23+ exhib-
ited changes that are characteristic of DNA binding. Large hypo-
chromicity in both π®π* and MLCT absorption bands as well as 
accompanying bathochromic shifts are observed; these changes 
are typical for an intercalative binding mode.  
As expected from many previous studies on M(dppz) com-
plexes, including 13+, complex 23+ is initially non-luminescent in 
aqueous solutions, but on addition of CT-DNA, its emission is 
greatly and steadily enhanced, see SI for details.  The quantum 
yields and lifetimes of both complexes in MeCN and when bound 
to DNA in aqueous solution were also recorded. Given the results 
of our in-cell studies, vide infra, we also investigated the emission 
of DNA-bound 13+ and 23+in acidic conditions. As duplex DNA is 
relatively stable in acid conditions and large-scale structural 
changes and denaturing of genomic DNA - largely due to proto-
nation of nucleobase steps - are only observed at pH 3.5 and be-
low, 48-50 we recorded this latter data in citrate buffer at pH4, an 
acidity level found in the lysosome – Table 1.   
Table 1 Quantum yields and lifetimes for the emission hex-
afluorophosphate salts of 13+ and 23+ in MeCN and their chlo-
ride salts when bound to DNA in aqueous buffer at pH7 (Tris 
buffer) and pH4 (Citrate buffer). 
Complex Solvent Φ Lifetime (µs) 
13+ MeCN 2.5 ´ 103 162 
 pH7 1.4 ´ 103 145/33 
 pH4 9. ´ 104 167/27 
23+ MeCN 2.3 ´ 103 186 
 pH7 2.8 ´ 103 151/30 
 pH4 2.5 ´ 103 129/24 
 
In MeCN the emission characteristics of the hexafluorphos-
phate salts of both complexes are quite similar. Both show a single 
emission lifetime, with 23+ displaying a slightly longer lifetime. 
However, these lifetimes and associated quantum yields are en-
tirely comparable to those obtained for related complexes con-
taining the RuII(tpm)(dppz) fragment that we have previously 
studied. 43  
The water-soluble chloride salts showed no emission in neutral 
or acidic conditions until they were bound to DNA. Again, the 





















similar and they both display biexponential lifetimes that are 
comparable to data that was obtained in previous studies. 43 Nota-
bly, the lifetime of 23+ appears to shorten in acidic solutions and 
this may be related to the presence of protonatable amino groups 
in its linker, which may provide a mechanism to increase quench-
ing of the excited state at low pH. 
Fitting of the spectral change (emission maximum) to the 
McGhee-von Hippel model for binding to an isotropic lattice,51 
yielded a Kb of 5.5 × 105 M-1, a value that is almost identical to 
that observed for 13+, indicating that – unlike their di-RuII ana-
logues44  – the change of linker between the two complexes has 
little effect on the DNA binding properties of these systems. 
As previous cell-free studies on 13+ have demonstrated that it 
photo-cleaves DNA,43 similar studies were carried out on com-
plex 23+. The photocleavage ability of the new complex was as-
sessed using supercoiled pBR 322 plasmid DNA and analyzed by 
electrophoresis on an agarose gel. Surprisingly, even after pro-
longed irradiation for up to 60 mins over a range of concentra-
tions (10, 20 and 40 μM) no evidence of photo-cleavage was ob-
served. Despite the fact that the only difference between the 13+ 
and 23+ is the linking tether, these observations suggest that the 
ReI(dppz)-based excited state of 23+ is not sufficiently high 
enough in energy, or too short-lived, to produce DNA damage. 
As it is known that MLCT excited states can be quenched 
through photo-induced electron transfer processes involving ni-
trogen lone pairs, 52,53 the photophysics of the two complexes was 
investigated in more details. 
Time resolved absorption spectroscopy 
Ultrafast transient absorption measurements were carried out 
on the chloride salts of 13+ and 23+ in TRIS buffer with and with-
out CT-DNA (Figure 2). 
The excited state spectra of each complex was obtained under 
400 nm excitation as previous studies have shown that this popu-
lates MLCT states localized on both units.23,25,44,46 The resultant 
spectra are dominated by a broad short-lived transient absorp-
tion, in the range 500 – 700 nm, which is consistent with the pop-
ulation of a metal®dppz(p*) 3MLCT state.54 The bands at ~470 
nm and ~600 nm, indicative of dppz-radical anion coordinated to 
a metal center, are also present;55 an absorbance at 475 nm has 
also been reported for a dppz-localised excited state.56 In the ab-
sence of DNA, the transient spectra decay almost to the baseline 
within several nanoseconds, with the somewhat faster decay oc-
curring for 23+ (t = 160 ps) than 13+ (t = 210 ps). 
Whilst the detailed photophysical study is not the focus of this 
work, we note that the transient spectral profile is time-depend-
ent, which is indicative of several excited states being present 
(Re/phen MLCT, Ru/phen MLCT, and dppz-based excited 
states) as is typical for metal complexes of the dppz-ligand.56 
Whilst these excited states undergo ultrafast decay in water, with 
the addition of DNA, the spectra do not decay to the baseline 
within the instrument-limited duration of the experiment (7900 
ps). This difference is consistent with the DNA “light switch” ef-
fect common to {Ru(dppz)} species, as well as the observed in-
crease in luminescence for these complexes upon binding to 
DNA.57 
In the presence of DNA 13+ exhibits distinctive spectral fea-
tures at 600 nm, and 550 and 475 nm, which are comparable with 
the early- and late-time spectra of the complex respectively in the 
absence of DNA. The absorptions >600 nm are much more 
pronounced then in the case of 23+ (Fig. 2B and 2D). The differ-
ence in the spectral profiles is a strong indication that photoin-
duced reactions of 1 and 2 with the DNA are affected by the na-
ture of the linker. To gain insight into the electronic structure of 
these compounds and their differences, quantum based DFT cal-
culations were performed. 
 
Figure 2. Transient absorption spectra at selected time delays, 5 µM 
complex or 5 µM complex:25 µM bp-1 CT-DNA A) 23+ in TRIS 
buffer B) 23+ in TRIS buffer with CT-DNA C) 13+ in TRIS buffer D) 
13+ in TRIS buffer with CT-DNA.  
Computational Studies 
    All calculations were performed using Gaussian09, version 
D.0158 using B3LYP/GD3BJ 59,60 using the procedure outlined 
in the Supporting information, focusing on their behavior in solu-
tion without any DNA present. Calculations performed for a vari-
ety of conformers led to the lowest energy singlet (S0) and triplet 
(T1) states for 13+ and 23+. This analysis also included analogous 
calculations where four water molecules were explicitly included, 
which we label 1w3+ and 2w3+. The results of this analysis are 
summarized in Figure 3. Overlays of the singlet and triplet states 
for 13+ and 23+ are given in the supporting information (Figure 
S11 and S12), where we also show the overlap between the low-
est energy singlet isomer of 1w3+ and 2w3+ and their first triplet 
state (Figure S13 and S14).  
The overlays show that, in each individual case, these conform-
ers are structurally very similar. However, it is clear from Figure 3 
that there are a number of qualitative differences between 13+ and 
23+; differences that are largely retained in a parallel comparison 
of 1w3+ and 2w3+. First, while the two dppz units of both 13+ and 
23+ approach co-planarity, due to the differences in linker length, 
they are close to parallel in 13+/1w3+ but almost orthogonal to 
each other in 23+/2w3+. This has consequences for both adsorp-
tion and emission spectra, as transition dipole moments involving 
dppz will be mutually amplified in the structure of 13+/1w3+, but 
this will be more difficult in the case of 23+/2w3+. 
A second structural difference is that in the case of 13+ the Ru-
dppz moiety is closer in space to the flexible linker moiety of the 
bridging ligand than the Re-dppz, whereas for 23+ that situation is 
reversed. The inclusion of water molecules results in the Re-dppz 
















































Figure 3: Calculated structures for the lowest singlet and triplet 
states for 13+, 23+, 1w3+ and 2w3+. Panel (a): 13+ (S0). Panel (b): 
23+(S0). Panel (c): 13+(T1) with spin density (isosurface at 0.0004 
with a spin purple and b spin red) superimposed. Panel (d): 23+(T1) 
with spin density (isosurface at 0.0004 with a spin purple and b spin 
red) superimposed. Panel (e): 1w3+ (S0). Panel (f): 2w3+(S0). Panel 
(g): 1w3+(T1) with spin density (isosurface at 0.0004 with a spin 
purple and b spin red) superimposed. Panel (h): 2w3+(T1) with spin 
density (isosurface at 0.0004 with a spin purple and b spin red) su-
perimposed. 
A final difference between the two structures is that the 
pyridyl-group of the tether ligand coordinated to the Re center 
has a different orientation in 13+ compared to 23+, again this fea-
ture is maintained in the structures of 1w3+ and 2w3+. Due to com-
putational time restraints an exhaustive conformational search 
was not possible; so - to ensure that fortuitous sampling did not 
cause these findings - the position of the metal centers and ancil-
lary ligands for 13+, 23+, 1w3+, and 2w3+ were inverted and re-opti-
mized. In both cases, this resulted in energies that were higher 
than for the situation depicted in Fig 3 (See SI for final struc-
tures). How the structural differences discussed above might af-
fect photo-excited states of the two complexes in water (without 
any DNA present) was then computationally investigated. 
Comparisons between the simulated UV-VIS spectra for 13+ 
and 23+ on the one hand and 1w3+ and 2w3+ on the other hand 
shows that, overall, they are all remarkably similar (Figures S15 
and S16, SI). However, a detailed wave function analysis using 
the TheoDORE program61 is more revealing. Whilst the range of 
oscillator strengths between 13+ and 23+ is quite similar, the char-
acter of the transitions is very different, as is clear from Figures 
S17 and S18 in the SI. Similar images are also provided for 1w3+ 
and 2w3+ in Figures S19 and S20. Two particular aspects are 
worth highlighting.  
First, for 13+, the 1MLCT excitations at low energy are mainly 
due to charge transfer from the Ru center onto both dppz moie-
ties and its p-p* transitions also involve vertical and cross-excita-
tions transitions to and from both dppz moieties. Although 23+ 
displays similar p-p* transitions, its strongest 1MLCT transitions 
are largely restricted to the Ru-dppz moiety. Secondly, the linker 
for 13+ is not involved in any of the strong transitions (f > 0.01), 
whereas in the case of 23+ the linker is involved - either as a source 
or as a destination of the excitation. This suggests that for 23+ the 
character of the amino-groups in the linker can change dramati-
cally after excitation, altering the photochemical behavior in bio-
logical systems. This is supported by our calculations on 1w3+ and 
2w3+, where there are more transitions involving the linker for 
2w3+ than for 23+; it is also clear that the oscillator strengths for 
1w3+ and 2w3+ are lower on the whole than for the case without 
coordinated water.  
 Finally, the nature of the emission from the triplet state was 
considered. As is clear from Fig. 3 (panels (c) and (d)) the spin 
density of the first triplet state of 13+ and 23+is dramatically differ-
ent. In 13+ it is largely centered on the Ru-dppz, whereas for 23+ it 
is spread over both dppz units. The same is the case for 1w3+ and 
2w3+ as is clear from panels (g) and (h). The emission wave-
lengths for 13+ and 23+ (as a 0-0 transition) are calculated to be 
667 and 725 nm, respectively, and the equivalent figures for 1w3+ 
and 2w3+ are 748 and 785 nm.  
The spread of the wave function over both dppz units results in 
a red-shift of the emission wavelength for 23+/2w3+, which is to be 
expected. For both 23+ and 2w3+ the calculated wavelength is 
longer than experimental figure. Most likely this is because that in 
these initial calculations conformational motion of the molecule, 
is not taken into account, although future calculation may also re-
quire a more complete solvation shell to describe this transition. 
Certainly, calculations on an extended structure for 23+ shows 
that emission wavelength shifts to 652 nm (696 nm for 2w3+), giv-
ing credence to the hypothesis that geometrical motion play a 
role in the energy of the excited state. However, the lowest singlet 
and triplet structures for this extended structure are calculated to 
be 91 kJ mol–1 and 111 kJ mol–1 higher in free energy than the 
those for the structure in Figure 3(b), making it unlikely for these 
specific structures contribute to the conformers in solution. For 
all conformers of the extended structures of 13+ and 23+ studied 
(with or without water coordinated), the two metal centers are 
essentially decoupled (see Figures S21-S24), although some 
strong cross-ligand excitations from Ru to the Re-moiety are still 
present. A similar comparison of energies with 2w3+ is more difficult. 
A minimum number of water molecules needed to describe the solva-
tion shell of each conformation of 2w3+ without biasing the results 
was chosen; consequently this number differs for the extended and 
closed conformers, meaning that any direct comparison of their ener-
getics would be non-trivial. 
Although an exhaustive conformational search was beyond the 
scope of this study, the completed calculations echo the spectro-
scopic experiments and provide insights into why the photophysi-
cal properties of 13+ and 23+ are affected by their linking ligand 
and illustrate how the nature and conformation of the tether moi-
ety have profound effects on the excited state of these linked sys-
tems. Given the flexibility of both tethers, the folded and 
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extended structures described herein are probably limiting forms 
of a range of dynamic conformers in solution although the calcu-
lations clearly indicate that structures with co-planar dppz units 
will be energetically preferenced, at least in simple solutions.  
As no cell-based studies on heterometallic Ru/Re dppz com-
plexes have as yet been reported, the cytological properties of 13+ 
and 23+ were then investigated.  
Cell studies 
Initially the cytotoxicity of both 13+ and 23+ were determined 
over a range of concentrations (1-200 µM) to obtain 48 hour IC50 
values against both the A2780 cisplatin sensitive cell line and the 
cisplatin resistant variant A2780cis cell lines (Table 2). 
Table 2 IC50 (µM) values for A2780 and A2780cis cells 
treated with complexes 13+ and 23+  
Cell line 
48 hr IC50 con. (μM) 
13+ 23+ cisplatin 
A2780 79 11 2 
A2780cis >200 21 22 
 
The IC50 for 13+ against A2780 cells was determined to be 79 
µM, indicating that this complex is considerably less potent than 
cisplatin (IC50 = 2 µM) under the same conditions. Indeed, de-
spite the expected drop in activity against the resistant A2780cis 
line (IC50 = 22 µM), cisplatin is still much more potent than com-
plex 13+, which also displays a large decrease in activity against 
this line. 
Surprisingly, complex 23+, displays appreciably higher cytotox-
ity against A2780 cells than 13+ and is equipotent with cisplatin 
against A2780cis cell line. These data also reveal that the Re-
sistance Factor (RF = IC50(A2780)/IC50(A2780cis) for 23+ (RF 
<2) is much lower than cisplatin (RF = 11), indicating a lack of 
cross-resistance with the platinum-based therapeutic.  
Although complex 23+ does not cleave DNA in cell-free condi-
tions, the in-cell phototoxic activity of both complexes against the 
two cell lines was investigated using a previously published proto-
col. Again surprisingly, the phototoxicity of both complexes was 
minimal. At irradiation of 48 J cm-2, the phototoxic indices of 
complexes 13+ and 23+ were determined as ~1.2 and 2 respectively 
(See SI). For complex 23+ these findings are consistent with the 
lack of DNA cleavage reported in the previous section. However, 
as 13+ is capable of photocleaving DNA in cell-free studies, the 
lack of phototoxicity is somewhat unexpected. To investigate this 
issue in more detail further experiments on the uptake of the 
complexes were carried out.  Given that complexes 13+ and 23+ dis-
play off-on switching effects and do not display greatly enhanced 
phototoxicity we initially exploited their emission properties by 
resolution-limited microscopy.  
Treatment of A2780 cells with either 13+ or 23+ leads to stain-
ing; however, the details of the staining patters are strikingly 
different. Luminescence imaging using widefield microscopy re-
vealed that, at all concentrations, complex 13+ only displays emis-
sion from the nucleus. Although the complex could also be im-
aged using the super-resolution technique structured illumination 
microscopy, SIM, Figure 4, it exhibits rapid photobleaching, 
which hampered further imaging studies. Contrastingly, 23+ dis-
plays negligible photobleaching when imaged in cells and its in-
tracellular localization is concentration-dependent. At concentra-
tions below its IC50 value, the intracellular emission of 23+ appears 
punctated and only present in the cytosol. However, at higher 
concentrations - particularly above the IC50 - distinct nuclear 
staining is also observed. 
 
Figure 4. Comparative widefield (A) and SIM (B) images of A2780 
cells stained with complex 13+ (100 µM) with corresponding inten-
sity line profile shown below the image. 
We have recently demonstrated that a photostable dinuclear 
RuII complex containing a rigid planar bridging ligand is an excel-
lent probe for not only SIM but a second super resolution tech-
nique, STED microscopy.47 STED is particularly attractive as it 
can theoretically attain infinitely high resolution and experi-
mental resolutions of ≤50 nm are frequently obtained.62-64 How-
ever, selective deactivation of the photo-excited probe through a 
depletion beam requires luminophores with highly photostable 
excited states.65 The lack of photobleaching of 23+ prompted us to 
explore whether its overall optical properties were compatible 
with demands of STED protocols. Using high-resolution HyVo-
lution, deconvoluted laser scanning confocal microscopy (d-
LSCM) - which in itself doubles lateral resolution compared to 
conventional confocal methods – and deconvoluted STED (d-
STED) (using a 775 nm depletion beam into the low energy edge 
of the 3MLCT band) the punctated emission produced by 23+ 
within cells at low treatment concentrations was investigated by 
co-staining with commercial lysotracker and mitotracker probes. 
– Figure 5. The increased sensitivity of STED facilitated these ex-




Figure 5. Super resolution deconvoluted Stimulated Emission Depletion (d-STED) nanoscopy of MCF-7 cells compared to deconvoluted Laser 
Scanning Confocal Microscopy (d-LSCM) using Leica HyVolution employing 0.5 airy units pinhole aperture. Images A-B: Lysosomal staining at 6 
µM [2]Cl3, deconvoluted images shown in red (A), Lysotracker in Green (B), and [2]Cl3 STED in cyan (C). Merged d-LSCM images of [2]Cl3 in 
red and Lysotracker in green are shown in the white-framed inset colocalization maps, displaying the colocalized objects in yellow (D); 2D scatter 
plot of the pixel colocalisation distribution, and calculated Pearson’s coefficients (D). Merged images of d-STED of [2]Cl3 in Red, and d-LSCM of 
Lysotracker in green are shown in the white-framed inset colocalization maps, displaying the colocalised objects in yellow (E); scatter plot of the pixel 
colocalisation distribution, and calculated Pearson’s coefficients (E). Merged images of d-LSCM in red and d-STED of [2]Cl3 in cyan are shown (F); 
normalised intensity line profile is shown in (G) of the white line drawn in (F); enhancement of the resolution by d-STED can be observed in the 
compared-merged images, as well as in the full-width-half-maximum (FWHM) of the line profile. Images H-K: Deconvoluted images  of mitochon-
drial staining with 6 µM [2]Cl3, of RuRe shown in red (H), Mitotracker in Green (J), and [2]Cl3,  STED in cyan (K). Merged d-LSCM images of 
[2]Cl3, in green and Mitotracker in red are shown in the white-framed inset colocalization maps, displaying the colocalised objects in yellow (L); 2D 
scatter plot of the pixel colocalisation distribution, and calculated Pearson’s coefficients (L). Merged images of d-STED of [2]Cl3, in green, and d-
LSCM of Mitotracker in red are shown in the white-framed inset colocalization maps, displaying the colocalised objects in yellow (M); scatter plot of 
the pixel colocalisation distribution, and calculated Pearson’s coefficients (M). White squared insets in (H), are magnified in (i, ii); merged images of 
[2]Cl3,  on d-LSCM in red and on d-STED in cyan are shown (N and O); normalised intensity line profile of the white line drawn in (N) is shown in 
(P); normalised intensity line profile of the white line drawn in (O) is shown in (Q); enhancement of the resolution by d-STED can be observed in 
the compared-merged images, as well as in the FWHM of both line profiles 
Both the high- and super-resolution studies confirmed that the 
complex localizes in lysosomes and mitochondria, however there 
were some interesting differences in the results. Analysis of the d-
LSCM data for the co-localization of 23+ led to a Pearson coeffi-
cient of 0.37 with lysotracker and 0.49 with mitotracker – Fig 5D 
and E. However, when the analyses were carried out on the same 
cells using the substantially higher resolutions available through 
STED, Fig 5L and M, these figures changed to 0.56 and 0.21 re-
spectively indicating that emission is largely observed within lyso-
somes rather than mitochondria. 
 As described above, in cell-free conditions 23+ only displays 
emission in neutral and acidic solution found in a lysosome when 
bound to DNA, suggesting the complex is not freely solvated in 
the lysosomal compartment. Although it is now known that lyso-
somes can contain nucleic acids through direct uptake mecha-
nisms66,67, it is well-established that light-switch complexes are 
also switch on in many other lipophilic environments68-71 includ-
ing lipid-rich regions72. The fact that emission is seen from lyso-




Figure 6. Kymographs showing time dependent cell permeation and localization of [2]Cl3 in MCF7 cells at different intracellular focal planes imaged 
through d-STED. Uppermost left-hand side: top image show three MCF-7 cells stained with 500 µM 23+ before starting the time-lapse imaging. The 
red dashed region of interest (ROI) is zoomed-in and displayed to the right hand side. The middle image shows the supranuclear plane of the ROI. 
The false colours observed correspond to the time-lapse evolution of the cellular components; as displayed in the scale below. First time points are 
shown in blue and the last time points in light yellow. This 2D kymograph representation over 5 minutes reveals the evolution of lysosomes and mito-
chondria imaging, as well as the plasma membrane. The top uttermost right-hand sided image shows the same ROI but at a different z-axial position, 
the nuclear equatorial plane. Similarly, the 2D kymograph representation over 5 minutes allows tracking 23+; nuclear staining, over lysosomes and 
mitochondria localization, becomes more apparent towards the end of imaging time period,.  Below, the ROIs of the two different planes investigated 
are shown after 1min, 2.5 and 5 minutes of time-lapses. From each image a yellow dashed square inset is zoomed-in and shown at its right-hand side 
(i,ii,iii,iv,v,vi)  , where super-resolved image of the lysosomes, mitochondria, plasma membrane and nuclear membrane are shown; the white line in 
each image corresponds to the accompanying normalised intensity profile . 
Although these data confirm that emission from 23+ is from the 
two organelles, the quantitative differences between LSCM and 
STED indicate that higher resolution technique more successfully 
deconvolutes the optical signals of 23+ and the two commercial 
probes. As mentioned above, at exposures to 23+, above its IC50 con-
centration nuclear staining was observed. This was confirmed by 
co-localization experiments. For example, at 500 nm concentra-
tions, cells co-stained with the nuclear DNA stain Hoechst 33342 
and imaged by widefield or super resolution techniques led to Pear-
son co-localization coefficients of >0.92 – See SI. Thanks to the 
photo-stability of 23+, on exposure to the complex at these concen-
trations the change in localization could be observed and visualized 
at STED resolutions in real time. 
Images taken immediately after exposure to the complex in the 
same concentrations used in co-staining experiments show that 
emission from 23+ initially localizes in mitochondria and lysosomes 
of live cells. But its characteristically bright luminescence rapidly 
migrates, with strong staining of the nucleus and particularly the 
nuclear membrane developing within five minutes, see Figure 6 for 
representative kymographs. The dynamics of this processes in both 
 8 
the supranuclear and equatorial planes are strikingly revealed in ac-
companying STED-based videos – see SI. As far as we aware this is 
the first time the temporal dynamics of optical probe uptake by live 
cells have been visualized at super resolutions. 
Although the intracellular luminescence of 13+ and 23+ confirms 
their uptake by live cells, this data is not quantitative, particularly as 
these complexes display a light-switch effect and thus only emit 
from lipophilic environments. To obtain a more complete under-
standing of this issue, inductively coupled plasma mass spectrome-
try (ICP-MS) was used to determine cellular accumulation of the 
two complexes in A2780 cells. 
After exposure of cells to 13+ and 23+, the fractionated ruthenium 
content in both nuclei and cytoplasm were determined. These data, 
which are summarized in Figure 7A, reveal that live cells take up 
complex 23+ at appreciably higher levels than 13+. Furthermore, at 
this exposure level, whilst both complexes accumulate preferen-
tially within the nucleus, it seems 23+ displays proportionally higher 
nuclear targeting, as the concentration distribution ratio between 
the nucleus and cytoplasm is 4.8:1 for 13+ and 5.4:1 for 23+ respec-
tively, Due to the combination of increased overall uptake and nu-
clear targeting, accumulations of  23+ within the nucleus is almost 
x2.5 times higher than  that of 13+. 
 
Figure 7. ICP-MS data for the uptake of 13+ (g) and 23+ (g) in (A) 
A2780 cells and (B) A2780cis cells  
The increase in intracellular concentration and nuclear targeting 
of 23+ suggests cell uptake causes the enhanced cytotoxicity of this 
complex relative to 13+. This hypothesis was further explored 
through analogous experiments with A2780cis cells. 
Previous studies have established that therapeutic resistance of 
A2780cis to cisplatin is due to more than one mechanism.73,74 Alt-
hough it is known that mismatch repair mechanisms are repressed, 
one of the main resistance mechanisms in this cell line involves de-
creased expression of the CTR1 copper transporter protein, result-
ing in a lowered intracellular concentrations of cisplatin.75 
 Therefore, to investigate whether the reduction in potency of 13+ 
and 23+ against A2780cis cells is also associated with changes in the 
intracellular accumulation of the complexes, ICP-MS studies on 
this line were also carried out – Fig 7B.   
Using identical conditions to those employed for the A2780 
study, it was found that there was a considerable decrease in intra-
cellular accumulation of the complexes within A2780cis cells. Alt-
hough live cell uptake of complex 23+ is again appreciably higher 
than 13+ by a factor of ~2.5, accumulation of both complexes is con-
siderably lower than in the A2780 line. For example, nuclear uptake 
of 23+ within A2780 cells is ×4 higher than in A2780cis cells.  
Conclusions 
For the first time, the cellular properties of mixed metal oligonu-
clear Ru/Re-dppz-based complexes and the effects of linking ligand 
on the cell uptake properties of dinuclear metallointercalators has 
been explored. In our original work on related homonuclear RuII-
systems, the linker employed in 23+ was chosen for its potential to 
mimic polyamines such as spermine and spermidine. These ubiqui-
tous biomolecules not only display non-specific binding to nucleic 
acids through electrostatic interactions, but are also established 
vectors for nuclear delivery. 
The comparison between 13+ and 23+ indicates that the linker 
does indeed improve cellular delivery and nuclear targeting. Some-
what unexpectedly the ultrafast transient absorption studies reveal 
that the linker also affects the photophysical properties of 23+, de-
creasing the relative population of a high-energy ReI(dppz)-local-
ized p/n ®p* state upon excitation.  These observations explain 
the low phototoxicity of 23+ and its inability to photo-damage DNA 
in cell-free conditions. The changes in excited state properties also 
accounts for the low in-cell photobleaching properties of 23+. Con-
trastingly, the rapid bleaching of 13+ explains its lack of photo-tox-
icity in live cells, even though it damages DNA in cell-free condi-
tions. 
The enhanced uptake and nuclear delivery of 23+ afforded by its 
tether only partially explains its increased cytotoxicity when com-
pared to 13+. For example, a comparison of the ICP-MS data for 
A2780 and A2780cis cells show that despite the decreased uptake 
of both 13+ and 23+ in A2780cis cells, 23+ largely retains its cytotoxi-
city and is thus potent at concentrations that are a order of magni-
tude lower than 13+ in the same cell line. This observation suggests 
that the enhanced potency of 23+ compared to 13+ may not solely be 
due to differences in uptake but may be a consequence of changes 
in biomolecular targeting properties. Studies to investigate this is-
sue in more detail will form the basis of future reports. It should 
also be noted that the homonuclear RuII analogues of 13+ and 23+  
are photo-stable but not classically cytotoxic.45 Therefore, it seems 
the distinctive properties of 13+ and 23+ may also be attributed to 
the substitution of a [Ru(dppz)]2+  unit with a [Re(dppz)]+ moiety.  
Finally, it is known that polyamines are readily protonated in cel-
lular conditions. Although no changes in emission characteristics 
across cells is observed, the preferential localization of 23+ within ly-
sosomes hints that – at least in the acidic conditions found within 
these organelles - the amine sites within its tether may protonate, 
yielding a more cationic form. This increased polarity would disfa-
vor trans-membrane diffusion out of the organelle. Consequently, 
studies to investigate the effect of pH on the physiochemical and 
photophysical properties of this complex are underway.  
In summary, we have identified a heterometallic metallointerca-
lator that displays good uptake into the nuclei of live cells, where it 
can be used as a probe for STED imaging protocols; the complex 
also displays promising cytotoxicity in a therapeutically resistant 
cancer line. Taken together, these properties mean that the new 
complex is an attractive lead for the construction of new 
theranostics compatible with super-resolution imaging. Derivatives 
that enhance the imaging capabilities and/or therapeutic activity of 




Experimental details, DNA titrations, additional transient absorption 
data, Cleavage gels, microscopic slide preparation/protocols additional 
images and colocalization studies, ICP-MS protocol and whole cell fig-
ures, details of cytotoxicity and phototoxcity studies, and STED-based 
videos showing uptake of [2]Cl4 at high exposure. In addition, the SI 
contains all computational details as well as coordinates of the final ge-
ometries of the optimizations. Additional references67-76 are referenced 
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